Clinical activity after fingolimod cessation: disease reactivation or rebound?

Jessica FrauM P SormaniA SignoriS RealmutoD BaronciniP AnnovazziE SignorielloG T ManiscalcoS La GioiaC CordioliB FrigeniS RasiaG FenuR GrassoA SartoriRoberta LanzilloM L StromilloS RossiB ForciE Cocconull null

Published in: European journal of neurology (2018)

The present study showed that more than 26% of patients are at risk of having a relapse within 6 months after fingolimod discontinuation. Nevertheless, the risk of severe reactivations and rebound is lower than has been previously described.

Keyphrases

multiple sclerosis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis